Withdrawal Why is stopping substance use so difficult?

Similar documents
Controlled Substance and Wellness Agreement

Non-prescription Drugs. Wasted Youth

BENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU

Substance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %

Drug & Alcohol Detox:

Delirium Information for patients and relatives. Delirium is common Delirium is treatable Relatives can stay to help us

The National Methamphetamine Symposium

AACN PCCN Review. Behavioral

Withdrawal.

Chapter 7. Screening and Assessment

Overview of Psychoactive Drug use

Substance Abuse Protracted Withdrawal

BASIC VOLUME. Elements of Drug Dependence Treatment

Admit date: 1-WM 2-WM 3.2-WM 3.7-WM 4-WM DSM-V diagnoses: Please list all diagnoses (psychiatric, chemical dependency and medical)

Medication is just part of the management of these illnesses. Other therapies are also helpful; you may wish to discuss these with your prescriber.

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Stabilization Algorithm

OPIOIDS FOR PERSISTENT PAIN: INFORMATION FOR PATIENTS

Substance and Alcohol Related Disorders. Substance use Disorder Alcoholism Gambling Disorder

Depression Fact Sheet

Working with Intoxicated People Case Studies

Zopiclone Orion. Date: , Version 1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN

Height: Weight: Neck Size: Does your work involve shift work? Yes No. Where did you hear about us: Physician Media Friend Other

Understanding the Impact of Drugs on Children. Jackie McReynolds Washington State University

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

WELCOME TO THE CRACKS IN THE ICE WEBINAR SERIES

Tobacco Cessation Toolkit

SEDATIVE-HYPNOTICS. Mr. D.Raju, M.pharm, Lecturer

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

What else do I need to know about antidepressant medicines?

Opioid dependence: Detoxification

Chapter 8 teachers 1) A drug is a substance, other than food which may: a) Give us energy b) Relax us when nervous c) Change our ways of thinking

How does cannabis affect my work performance?

SCREENING FOR COMMON MENTAL DISORDERS DEPRESSIVE AND ANXIETY DISORDERS SUBSTANCE USE DISORDERS

Complete the CE Checklist for Customized Symptoms. Page 1 of 6

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Trends, Tactics and Toxicity: Marijuana Movement on Missouri College Campuses. Janice Putnam PhD, RN Amy Kiger MS, ABD Kelly Skinner DNP, FNP-C

Alcohol. Fits Hallucinations. Hallucinations Brain damage. Cirrhosis Gastritis. Diabetes Vomiting blood

MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP

Mood, Emotions and MS

Common poly-substance abuse: MDMA, Ketamine, & Methamphetamine Clinical detection and management

ADULT INITIAL EVALUATION: Patient Form

ANTI-DEPRESSANT MEDICATIONS

Remote Alcohol & Other Drugs Workforce Northern Territory. Ice/Methamphetamines. Footprints across the Territory 1

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Drug abuse: Drug misuse Dependence abuse

MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution

understand the causes and effects of stress

METH CHECK. METHAMPHETAMINE Ways to Stay Safe NOT FOR GENERAL DISTRIBUTION

Cell body, axon, dendrite, synapse

Kelowna Sleep Clinic Dr. Ronald Cridland Inc Sleep Questionnaire

TOOL 1: QUESTIONS BY ASAM DIMENSIONS

HAMILTON DEPRESSION RATING SCALE (HAM-D) (HAM)

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults

MEDICATION GUIDE BuPROPion Hydrochloride Extended-Release Tablets, USP (SR) (byoo-proe-pee-on)

National Hospital for Neurology and Neurosurgery. Migraine Associated Dizziness. Department of Neuro-otology

Triage/Low Demand Shelter Screening Form

SCID-I Version 2.0 (for DSM-IV) Non-Alcohol Use Disorders

Understanding Mental Illness A Review of the Disorders

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

Mental Health First Aid at a Glance

Client s Name: Today s Date: Partner s Name (if being seen as a couple): Address, City, State, Zip: Home phone: Work phone: Cell phone:

attempts to commit suicide acting aggressive, being angry, or violent

Consumer Information Cannabis (Marihuana, marijuana)

MENTAL HEALTH AND MENTAL ILLNESS: OUR JOURNEY ACROSS THE CONTINUUM LLI PROGRAM OCTOBER 5, 2018 VIRGINIA F. RIGGS MS, MSN, RN

7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER ELEVEN CHAPTER OUTLINE. Substance Use Disorders. Oltmanns and Emery

Behavior Health Admission Information Form. Name Date

Zydus Pharmaceuticals USA Inc. MEDICATION GUIDE

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

What is the most important information I should know about Morphine Sulfate Oral Solution?

Buprenorphine Patch (Transtec Patch)

WELCOME TO THE NORTHSHORE UNIVERSITY HEALTHSYSTEM SLEEP CENTERS

COUPLE & FAMILY INSTITUTE OF TRI-CITIES AMEN ADULT GENERAL SYMPTOM CHECKLIST

MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution

Consumer Medicine Information

Tuscarawas County Health Department. Vivitrol Treatment Consent

MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only

130 Preston Executive Drive Cary, NC Ph(919) Fax(919) Page 1 of 6. Patient History

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

Managing Fatigue in Bone Marrow Failure Diseases

Patient Information Sheet: Baclofen for Alcohol Addiction.

Chapter 38 Substance Abuse and Eating Disorders

Activation-synthesis hypothesis. compulsive drug craving and use, despite adverse consequences. Addition. Amphetamines. Barbiturates.

substance use and mental disorders: one, the other, or both?

Dealing with Traumatic Experiences

THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved

In order to do this we want a consistent approach from Sheffield agencies to maximise the impact of this work.

Please review the following slides prior to class. Information from these slides will be used to answer patient cases. Come prepared!

Psychoactive drugs Drugs which affect mental processes. Legal but restricted (by prescription only)

Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers

Non-Motor Symptoms of Parkinson s Disease

Comorbidity of Substance Use Disorders and Psychiatric Conditions-2

PSYCHOLOGICAL DISORDERS CHAPTER 13 MEYERS AND DEWALL

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

GET OFF YOUR ACID 7-DAY SUMMER CLEANSE Client Workbook

Fatigue and Chronic Fatigue Syndrome

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

METABOLIC ASSESSMENT FORM

This initial discovery led to the creation of two classes of first generation antidepressants:

Transcription:

Withdrawal Why is stopping substance use so difficult? Withdrawal occurs in drug dependant individuals who stop or considerably reduce their drug use.

Definitions Dependence syndrome is characterized by : Tolerance, Withdrawal, Inability to cut down or control use, Behavioural changes in the areas of relationships, occupation, social/recreational activities, Continuation with use with the knowledge that it is harmful

Withdrawal is a state with a group of symptoms of variable clustering and severity. Occurs with absolute or relative withdrawal of a psychoactive substance. Withdrawal is time limited and related to the type and amount of substance being used before cessation or reduction. Withdrawal: Within the AOD sector it is that state that exists following the reversal of neuroadaptation to a psychoactive substance.

Definitions Neuroadaptation is the process whereby the body compensates for the presence of a chemical so that it can function normally. Neuroadaptation leads to tolerance and dependence.

Substance dependence DSM IV Presence of 3 or more of the following Tolerance; increasing dose to get similar effects to previous use Withdrawal; display withdrawal symptoms Larger amounts over a long period Unsuccessful efforts to cut down; history of relapses Time spent obtaining the substance replaces social, occupational or recreational activities; forego work, school or other activities to use Continued use despite adverse consequences; legal, family problems

A little about Neurotransmitters All drugs of addiction act on the dopamine neurotransmitter, except for benzodiazepines. This includes alcohol, nicotine and caffeine. A neurotransmitter, a chemical which transmits a message from one brain cell to the next. The effects of psychoactive substance use in the brain is the effect on neurotransmitters, their release, inhibition and reuptake. Alcohol increases the effects of inhibitory GABA neurotransmitter while inhibits the effects of excitory neurotransmitter glutamate and serotonin.

Normal Dopamine Function Video - Normal Dopamine Function.mht

Principles of Withdrawal Withdrawal from substance use carries with it risks of physical harm, psychological trauma, and sometimes (rarely) death. The aim of withdrawal management is to minimize the risks associated with withdrawal. Supportive care and client choice are crucial to success. Planning and co ordinating post withdrawal is an integral part of treatment.

Principles of Withdrawal The primary objective of withdrawal is to achieve the clients goals in relation to withdrawal from their substance use safely. These goals are determined by a thorough client intake interview and assessment. They need to client driven. Why does the client want to change? What is motivating the client to change their lifestyle? What's changed in them to bring them to this point in their life What s different this time?

Withdrawal Management A comprehensive ASSESSMENT is the fist step. It defines the risks Identifies the drug(s) Identifies health issues Identifies the most appropriate setting for withdrawal Identifies factors that will influence the success of withdrawal Builds the therapeutic relationship Formulation of a management plan

Psychosocial Factors Expectations of withdrawal Reasons for presenting at this time Past experiences of withdrawal Current understanding of withdrawal Ability to cope with withdrawal Supports for withdrawal Accommodation Clients social network extent and suitability Supportive family /friends Links with health professionals

Psychosocial Factors Barriers to withdrawal Isolation Transport Relationship issues Care of children House mates that use Legal issues Financial issues Work commitments

Withdrawal effects Exhaustion Irritability Mood swings Anxiety Agitation Cravings Disturbed Sleep Memory Impairment Lack of Concentration Flat, amotivated Lethargic Adhedonia Impulsive Depressed

Alcohol Alcohol withdrawal carries a significant risk to the health and wellbeing of the individual and can be life threatening

there is an alcohol related reason for admission/ assessment there is regular alcohol use of > 80 grams per day (males), > 60 grams perday (females) < 10 days after last drink (withdrawal usually commences within 6 24 hours of last drink, and may last 2 12 days) there is a history of alcohol dependence/significant previous withdrawal history AUDIT Score > 12

Cessation or reduction of alcohol use that has been heavy and prolonged Two or more of the following developing within several hours to a few days after cessation. Autonomic hyperactivity (sweating, pulse greater than 100 bpm) Increased hand tremor Insomnia Nausea or vomiting Transient hallucinations (auditory, visual, tactile, illusions) Psychomotor agitation Anxiety Generalized tonic clonicseizures.

Cannabis Cessation does not produce the severity of withdrawal symptoms associated with other substances. Although giving up the drug is difficult for long term users. Symptoms of anxiety, irritability, insomnia. Physical pain, headaches, abdominal pain. Nausea. Depressed mood

Synthetics Withdrawal Some of the reported withdrawal symptoms include: tachycardia (rapid heart beat) insomnia difficulty breathing constipation nausea difficulty eating weight loss. paranoia anxiety panic attacks (even when sober) severe memory problems severe confusion or disorientation fear of dying difficulty concentrating

Management Symptomatic relief Diazepam for the anxiety and agitation Buscopan for the stomach pains Generalised aches and pains mild pain relievers. Anti nausea medication. Psychosocial support. Reducing use strategies

Benzos Withdrawal usually mild. Users are often poly drug users Abrupt withdrawal can produce a rebound effect of increased anxiety and insomnia. Major complication is delirium and seizures Withdrawal is slow and gradual. Few clients are able to comply with treatment and obtain additional supply.

Opioid

Opioid Withdrawal Severity, onset and duration is related to the type, route of administration and half life of the drug. Opioid withdrawal is not life threatening for those without medical complications. Opioid withdrawal involves the reversal of neuroadaptation and withdrawal symptom management. Relapse rates are high as there is often an inability to complete withdrawal. Planning for post withdrawal support is an essential component of care, assisting clients to work towards their goals beyond withdrawal. There is a significant risk of over dose on relapse due to reduced tolerance

Opioid withdrawal. Symptoms and signs Symptoms Anorexia and nausea Abdominal pain Hot and cold flushes Bone, joint and muscle pain Insomnia and disturbed sleep Cramps Intense craving for opioids Signs Restlessness Yawning Perspiration Rhinorrhoea Dilated pupils Piloerection Muscle twitching restless legs(particularly while lying down) Vomiting Diarrhoea

Withdrawal Mangement Symptomatic relief. Nausea and vomiting Maxalon, Stemetil, Ondansetron. Muscle aches and pains paracetamol, ibuprofen. Diarrhoea lmodium, Lomital, Kaomagma. Abdominal Cramps Buscopan, Anxiety/aggitation Diazepam. Sympathic Nervous system activity (anxiety sweats G.I. Upsets, craving) Clonidine. Restless legs Diazepam, Baclofen, Magnesium

ATS Amphetamine Type Stimulants

What we see when someone is using amphetamines. Movement twitching restless fidgety moving about Facial may be flushed and or sweating, pupils dilated. Speech loud and rapid may be tangential, unable to keep on topic. Skin long term users may have scabs, injecting site abscess. Body long term users thin undernourished and very active Teeth ground down, discoloured, receded gums. Behaviour irritable, anxious may aggressive.

Video - Amphetamine effect on Dopamine function.mht

ATS withdrawal pattern The withdrawal pattern from amphetamines will vary according to the duration and level of use, general and mental health.the intensity and duration of symptoms varies, depending on a range of factors including: Duration of use Amount used Route of administration Pre existing mental health issue such as underlying depression or anxiety General level of health Psychosocial supports or lack thereof

Withdrawal Management Withdrawal symptoms can range form mildly uncomfortable to life threatening. It is not necessary for users to binge on amphetamines for long periods to experience these symptoms. Withdrawing from ATS is different from withdrawal from depressants (opiates, alcohol, cannabis) These symptoms are likely to be experienced to some extent after much shorter exposure and may be exacerbated by tiredness associated with lack of sleep or extended partying. Most will be poly drug users

3 Phases of Withdrawal I. Crash, 1 3 days. Recovery from exhaustion, lack of sleep and food. II. Peak, 2 10 days. Most intense phase of withdrawal symptoms. III. Residual, 2 10 weeks. Symptoms may persist for some time.

Memory of ATS use, high, happy, Non-stop energy, neurotransmitter effect Life s normal ups and downs ATS withdrawal, neuroadaptation, flat, low, slow

ATS withdrawal pattern phase one Crash 1 3 Days Symptoms Exhaustion Insomnia and/or hypersomnia (oversleeping) Craving sleep and food Vivid unpleasant dreams Irritability and depression Little craving for drugs Presentation Flat, exhausted, depleted May not participate in program, in need of sleep and food Vivid, terrifying dreams are common, Waking in night

Phase Two, 8 10 days This phase may last longer than 10 days The transition from phase 2 to phase 3, may not be all that apparent, Motivation to continue is key Anxiety and depression are real In treatment, they may present as medicationseeking when other clients are at end of withdrawal Psychosis like symptoms may reappear Unlikely to come in for treatment Support information for home withdrawal is very useful

To clients this may feel like... Strong urges and cravings to use Mood swings, feeling anxious, irritable or agitated, or feeling flat and lacking energy Poor sleep Poor concentration General aches and pains, headaches Increased appetite (very hungry) Strange thoughts, such as feeling that people are out to get you. Misunderstanding things around you (e.g. Seeing things that aren t there)

ATS withdrawal Phase Two Peak Symptom last 8 10 Days User feels physically and emotionally awful, Lacks energy Increased appetite, Generalised aches and pains, Experiences anxiety, sleeplessness Psychomotor retardation* * what s this? Next slide Poor concentration Depression, risk time for self harm or suicide Strong drug cravings and May have re emergence of psychotic features such as misperceptions, paranoia and hallucinations.

Some examples of "psychomotor retardation" may include the following: Unaccountable difficulty with carrying out what are usually considered "automatic" or "mundane" self care tasks for healthy people, (i.e., without depressive illness). Real physical difficulty performing activities that normally would require little thought or effort, such as walking up a flight of stairs, getting out of bed, preparing meals and clearing dishes from the table. Tasks requiring mobility suddenly or gradually and inexplicably seem to be "impossible". Activities such as shopping, getting groceries, caring for the daily needs of one's children, and meeting the demands pertaining to employment or school are commonly affected. http://en.wikipedia.org/wiki/psychomotor_retardation

Psychomotor agitation Psychomotor agitation is a series of unintentional and purposeless motions that stem from mental tension and anxiety of an individual. This includes pacing around a room, wringing one's hands, pulling off clothing and putting it back on and other similar actions. In more severe cases, the motions may become harmful to the individual, such as ripping, tearing or chewing at the skin around one's fingernails or lips to the point of bleeding. http://en.wikipedia.org/wiki/psychomotor_agitation

Support in the Peak phase: Follow organisational protocols for suicidal/self harm behaviours Communicate with the client, ask, inquire, be interested Monitor and observe their behaviour Reassurance and support them Ask for check ins Discuss Urge surfing and craving for substance Remove sharps/blunts/ objects of risk Give client as much control and responsibility for self monitoring as possible Seek medical advice regarding medication Consult a medical officer, doctor, nurse Encourage Participation in tasks with others Provide Encouragement for each stage and day Provide relaxation strategies Provide structured activities which do not require high levels of concentration (meal preparation, gardening, games, walks)

ATS withdrawal Phase Three 1 8 Weeks Residual symptom phase Episodic cravings for drugs, may be very strong Insomnia Poor concentration Fluctuate between restlessness and lethargy Lack of motivation Low mood Depression Anxiety Psychomotor retardation

ATS Summary Mental health; Depression, low mood, anxiety, cognitive impairments are real Withdrawal vs. neuroadaptation withdrawal may last 8 weeks, recovery may take months Duration of withdrawal may be up to 8 weeks Maintaining commitment and engagement is the challenge Peak phase behaviour, self harm, mood, psychosis, and aggression may require closer attention Longer term requires continuity of care and commitment, psychosocial support, ongoing treatment, aftercare

Summery of Withdrawal Withdrawal priorities are safety, outcome, choice Comprehensive assessment: Predict the risks of withdrawal Identify the clients needs to enhance the chances of successful completion. Formulation of a management plan with active involvement of the client, use of withdrawal scales Build the therapeutic relationship. Identify motivations for change Identify barriers to success Support is critical to the success of treatment

Benzos CHEERS!

Resources Alcohol and other drug withdrawal: Practice Guidelines 2012. Turning Point Alcohol and Drug Centre. NSW Drug and Alcohol Withdrawal. Clinical Practice Guidelines 2007 NSW Dept. Health. Preparing for Methamphetamine Withdrawal 2pg pdf doc.: www.jdcounselling.com.au/ www.bluebelly.org.au an online harm reduction, support and information source for psychostimulant users, interactive. Getting through amphetamine withdrawal, A guide for people trying to stop amphetamine use, Turning Point, Alcohol and Drug Centre, or read information online, both at : www.meth.org.au/ Alcohol and Drug Service TAS Dept. Health. Me Salvation Army Bridge Centre Hobart. The internet